IL19 and neoplasm: A Treg-like subset (C8_CD4T_2), which is enriched in TMZ-resistant tumors, was decreased, while a γδ T cell cluster with antitumor activity [29] was significantly increased in IL-19 antibody-treated GL261/TMZ-resistant tumor-bearing mice.